Blog
About

2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Incidence and Predictors of Bleeding After Contemporary Thrombolytic Therapy for Myocardial Infarction

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references 13

          • Record: found
          • Abstract: not found
          • Article: not found

          Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Hemorrhagic Events during Therapy with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin for Acute Myocardial Infarction

                Bookmark

                Author and article information

                Journal
                Circulation
                Circulation
                Ovid Technologies (Wolters Kluwer Health)
                0009-7322
                1524-4539
                June 03 1997
                June 03 1997
                : 95
                : 11
                : 2508-2516
                Affiliations
                [1 ]Duke University Medical Center (S.D.B., C.B.G., K.S.P., K.L.L., R.M.C.), Durham, NC; University of Massachusetts Medical School (J.M.G.), Worcester; Thoraxcenter Erasmus Universiteit (M.S.), Rotterdam, Netherlands; the University of Alberta (P.W.A.), Edmonton, Alberta, Canada; and The Cleveland (Ohio) Clinic Foundation (E.J.T.).
                Article
                10.1161/01.CIR.95.11.2508
                © 1997

                Comments

                Comment on this article